Company overview
PHCbi provides laboratory equipment including ultra-low temperature freezers, refrigerators, CO2 and multigas incubators, autoclaves, and cell expansion systems for life science and pharmaceutical research. Their solutions support storage of biologics, cell lines, vaccines, and reagents with features like VIP insulation, energy efficiency, and real-time metabolic monitoring. Trusted by top pharmaceutical companies worldwide for reliability, uniformity, and compliance in preservation, incubation, and sterilization.
PHC Holdings Corporation is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include phcbi, ultra low temperature freezers, laboratory incubators, pharma refrigerators, cell expansion systems.
Structured facts
- Website
- https://www.phchd.com
- Markets served
- United States & Americas
- Keywords
- phcbi, ultra low temperature freezers, laboratory incubators, pharma refrigerators, cell expansion systems
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What laboratory equipment does PHCbi offer for pharma and life sciences?
- PHCbi offers ultra-low temperature freezers, pharmaceutical refrigerators, biomedical freezers, CO2 and multigas incubators, autoclaves, and the LiCellGrow cell expansion system for storage, incubation, sterilization, and cell culture in research and production.
- What regulatory and performance features do PHCbi products have?
- Products feature ENERGY STAR certification, VIP vacuum insulation for energy efficiency, inCu-saFe antimicrobial interiors, stable temperature uniformity, fast recovery after door openings, and real-time monitoring of cell metabolism for compliant, reliable operation in pharma and biotech labs.
- In which geographies does PHCbi operate and support customers?
- PHCbi delivers equipment worldwide to medical facilities and life science research, with operations in APAC, US, Japan, and other select countries, trusted by the top 20 pharmaceutical companies globally.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
